Funding for this research was provided by:
H2020 European Research Council
Knut och Alice Wallenbergs Stiftelse
Marianne and Marcus Wallenberg Foundation
Received: 15 November 2019
Accepted: 2 March 2020
First Online: 24 March 2020
Ethics approval and consent to participate
: The study was approved by the regional ethical committee at Lund University, Lund, Sweden. All participants gave their written informed consent to participate in the study.
: Not applicable.
: EB, ES, DVW, and SP declare that they have no competing interests. OH has acquired research support (for the institution) from Roche, GE Healthcare, Biogen, AVID Radiopharmaceuticals and Euroimmun. In the past 2 years, he has received consultancy/speaker fees (paid to the institution) from Biogen and Roche.